{"transactions":[{"id":4459602,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":179033,"kind":"person","name":"Matsuoka Grove","position":1,"cik":"0001673494","reported_name":"Matsuoka Grove","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2017-02-09T16:24:25.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 7, 2017, such that this option will be fully exercisable on February 7, 2021.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":20000,"derivative":{"exercise_price":3.3,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-009079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673494/000120919117009079/doc4.xml","form_type":"4"}},{"id":4602626,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":179033,"kind":"person","name":"Matsuoka Grove","position":1,"cik":"0001673494","reported_name":"Matsuoka Grove","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-15T18:47:27.000Z","date":"2016-09-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning October 13, 2016, such that this option will be fully exercisable on September 13, 2020.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":20000,"derivative":{"exercise_price":3.06,"expiration_date":"2026-09-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-141652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673494/000120919116141652/doc4.xml","form_type":"4"}}]}